Physicians and patients need to be aware of a potentially serious malfunction with a device from medtech firm Medtronic plc designed to treat heart failure, according to a 28 April letter to health care providers from the Food and Drug Administration.
The US agency says patients with the Medtronic Heartware Ventricular Assist Device (HVAD) System that appear to have pump thrombosis may have a welding defect in the internal pump, which...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?